ATMP regulation in EU and FDA

Advanced therapy medicinal products (ATMPs), including gene therapy, cell therapy, tissue engineering or combined ATMP products, offer groundbreaking new opportunities for the prevention and treatment of many diseases. As a result, the field of ATMP development is fast-growing in both, the EU and US. This webinar is intended to highlight the main characteristics, similarities and differences of ATMP regulation between the EU and the US, including legal basis, classifications, involved regulatory bodies, procedures during development and marketing pathways.

[@E_like_ela]

Thank you, it helped so much.

[@moviegirl611]

Very comprehensive overview. Thank you @Asphalion and Joel Montané!
Question: Is there a way to get captions in English for this video? For me, RUclips is auto-generating in Spanish even though the presentation is clearly in English.

[@richardl3494]

Why can't you speak clearly?